Creso Pharma Limited announced appointments of Mr. William Lay as Chief Executive Officer. Mr. William Lay is an experienced cannabis executive and previously served as Executive Vice President - Strategy, Origination & Operations at Creso Pharma. Mr. Lay began his career with leading Canadian full service financial investment bank, BMO Capital Markets through roles across Canada and London.

Over the last four years, Mr. Lay has managed and supported over CAD 5 billion in cannabis M&A transactions, including leading the acquisition in the history of the cannabis sector. In his new role as CEO and Managing Director of Creso Pharma, he will progress the Company's North American focused growth strategy, as well as Creso Pharma's proposed NASDAQ dual listing. Mr. Lay will also oversee the Company's global operations, including Creso Pharma's Swiss division and potential new market entries.

Creso Pharma plans to leverage Mr. Lay's extensive expertise to assess strategic, value accretive acquisitions in regions where it has an existing footprint, as well as for expansion purposes, with a particular focus on North America.